Lai CJ；Bao R；Tao X；Wang J；Atoyan R；Qu H；Wang DG；Yin L；Samson M；Forrester J；Zifcak B；Xu GX；DellaRocca S；Zhai HX；Cai X；Munger WE；Keegan M；Pepicelli CV；Qian C “Cancer research” 2010 Receptor tyrosine kinase inhibitors recently become important therapeuticsfor your a number of cancers. However, mainly because of the heterogeneous and dynamic nature of tumors, the advantages of these agents is oftentimes hindered
(Read More…)
